Patient Guide: Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 168 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06082167
Status: ACTIVE_NOT_RECRUITING
Condition: Head and Neck Squamous Cell Carcinoma
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 168 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Fullerton, California
  • Orange City, Florida
  • Tampa, Florida
  • • And 165 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily